Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Join a comprehensive webinar featuring Dr. Marc Steben and Dr. Stefan Riedel as they explore the evolving landscape of HPV testing and primary screening strategies. Learn about the World Health Organization's global cervical cancer elimination strategy, which emphasizes high-performance HPV DNA testing as the preferred primary screening method over traditional cytology. Discover how HPV primary screening enables risk stratification through genotyping, leading to more effective triage and personalized patient care. Examine the burden of cervical cancer, screening principles, and guidelines while understanding the paradigm shift from cytology/cotesting to primary screening. Gain valuable insights into laboratory perspectives on HPV testing, including test menu decisions, the advantages of in-house testing versus reference laboratory testing, and the role of primary screening and HPV genotyping in assay selection. Medical professionals can earn PACE credits through this 73-minute educational session that bridges clinical practice with laboratory medicine in the fight against cervical cancer.
